WallStreetZenWallStreetZen

NASDAQ: AVIR
Atea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atea Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-03-1160,000$1.24
$74.40kBuy
Jeanpierre SommadossiPresident CEO and Chairman2026-02-03300,000$1.24
$372.00kBuy
Janet Mj HammondChief Development Officer2026-01-3114,136$4.24
$59.94kSell
Maria Arantxa HorgaChief Medical Officer2026-01-3116,073$4.24
$68.15kSell
Jeanpierre SommadossiPresident CEO and Chairman2026-01-31106,093$4.24
$449.83kSell
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2026-01-3116,104$4.24
$68.28kSell
John VavrickaChief Commercial Officer2026-01-3111,570$4.24
$49.06kSell
Wayne FosterEVP Chief Accounting Officer2026-01-3112,132$4.24
$51.44kSell

1 of 1

AVIR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVIR insiders and whales buy or sell their stock.

AVIR Shareholders

What type of owners hold Atea Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.93%11,950,772$49.48MInstitution
Blackrock Inc10.54%8,435,437$34.92MInstitution
Bml Capital Management LLC8.82%7,058,657$29.22MInstitution
Jeanpierre Sommadossi8.29%6,633,855$27.46MInsider
Cormorant Asset Management LP8.01%6,411,355$26.54MInsider
Andrew A. F. Hack7.02%5,615,659$23.25MInsider
Tang Capital Management LLC6.02%4,814,700$19.93MInstitution
Vanguard Capital Management LLC4.06%3,246,124$13.44MInstitution
Bain Capital Life Sciences Investors LLC2.95%2,360,638$9.77MInstitution
Two Sigma Investments LP2.33%1,864,164$7.72MInstitution

1 of 3

AVIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVIR72.85%27.15%Net BuyingNet Buying
EPRX42.33%0.00%
CMPX80.75%19.25%Net BuyingNet Buying
FENC4.51%95.49%Net SellingNet Buying
PRLD38.64%51.23%Net BuyingNet Buying
View Top Biotech Stocks

Atea Pharmaceuticals Stock Ownership FAQ

Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals (NASDAQ: AVIR) is owned by 75.10% institutional shareholders, 27.99% Atea Pharmaceuticals insiders, and 0.00% retail investors. Jeanpierre Sommadossi is the largest individual Atea Pharmaceuticals shareholder, owning 6.63M shares representing 8.29% of the company. Jeanpierre Sommadossi's Atea Pharmaceuticals shares are currently valued at $27.53M.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.